BWV

Investor Moves

Name	Value	Action	Change	Price	Current Price
BlackRockInvestor $707 AddQ2 2024 $707 -- --

Trade BWV

About Blue Water Vaccines, Inc.

Blue Water Vaccines, Inc. (BWV) operates as a biotechnology firm dedicated to the worldwide discovery and development of vaccines aimed at preventing infectious diseases. Currently in preclinical stages, their most prominent vaccine candidates are BWV-101, an influenza shot, and BWV-102, designed to counter H1 pre-pandemic threats. The company's developmental portfolio also includes other preclinical programs such as BWV-201, a vaccine addressing acute otitis media caused by Streptococcus pneumoniae; BWV-301, a combined vaccine for norovirus and rotavirus; and BWV-302, a dual-target vaccine for norovirus and malaria. Founded in 2018, BWV's operations are based in Cincinnati, Ohio.

CEO: Neil J. Campbell MA, MBA
IPO Date: Feb 18, 2022

Market Data

Open: $0.20
High: $0.20
Low: $0.1776
Volume: 520.3K
Avg Volume: 433.5K
52W High: $1.95
52W Low: $0.1601

Valuation

Market Cap: $3.4M
Enterprise Value: $-3.1M
Dividend Yield: 0.00%

Financials

Free Cash Flow: $-9.7M
Revenue: $815k
Net Income: $-14M
Cash: $5.2M
Debt: $49k

Events

EarningsMay 13

actual -6.71